Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

This health news summary explores various pharmaceutical developments including Novo Nordisk's phasing out of insulin pens, a ...

Kidney disease is a leading cause of death in America, killing more people than breast cancer or prostate cancer.

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

Eknath Chavan, a 62-year-old man from Mumbai, celebrates his diabetes remission after 18 years, fitting into his wedding suit ...

We need a health system that not only provides medication but also encourages a healthy lifestyle. Group empowerment, digital ...

World Diabetes Day — today, Nov. 14 — brings out the best in the diabetes community that continues to innovate year after ...

From what is understood, the campaign aligns with the International Diabetes Federation’s theme of "Diabetes and Well-being.

Researchers at the University of Copenhagen have identified a promising new drug target for weight loss which could revolutionise treatment for millions of people with obesity and type 2 diabetes. The ...

An estimated 5.6 million people in the UK are living with diabetes and rates are rising. Recent figures showed that 549,000 more people have been identified over the past year as being at risk of ...